Öncü B hücreli çocukluk çağı lösemisinde JAK2 geninde ilk kez tanımlanan homozigot delesyon

Kaynakça (10)

1. Butcher CM, Hahn U, To LB, Gecz J, Wilkins EJ, Scott HS, Bardy PG, D’Andrea RJ: Two novel JAK-2 exon 12 mutations in JAK2V617F- negative polycythemia vera patients. Leukemia 2008
2. 873 2. Pardanani AD, Levine RL, Lasho T, Pikman Y, Mesa RA, Wadleigh M: Prevalence and clinicopathologic correlates of JAK-2 exon 12 mutations in JAK2V617F-negative polycythemia vera. Leukemia 2007
3. 4 3. Laughlin TS, Moliterno AR, Stein BL, Rothberg PG: Detection of exon 12 Mutations in the JAK2 gene: Enhanced analytical sensitivity using clamped PCR and nucleotide sequencing. J Mol Diagn 2010
4. 12 (3): 278-282 4. Jeong GE, Kim HS, Kim SM, Lee HL, Yoo JN: Absence of JAK-2 exon 12 mutation in acute leukemias. Acta Haematol 2008
5. 39 5. Sulong S, Case M, Minto L, Wilkins B, Hall A, Irving J: The V617F mutation in JAK2 is not found in childhood acute lymphoblastic leukemia. Brit J Haematol 2005
6. 965 6. Kratz CP, Böll S, Kontny U, Schrappe M, Niemeyer CM, Stanulla M: Mutational screen reveals a novel JAK2 mutation, L611S, in a child with acute lymphoblastic leukemia. Leukemia 2006
7. 20 (2): 381-383 7. Malinge S, Ben-Abdelali R, Settegrana C, Radford-Weiss I, Debre M, Beldjord K, Macintyre EA, Villeval JL, Vainchenker W, Berger R, Bernard OA, Delabesse E, Penard-Lacronique V: Novel activating JAK2 mutation in a patient with Down syndrome and B-cell precursor acute lymphoblastic leukemia. Blood 2007
8. 109 (5): 2202-2204 8. Bercovich D, Ganmore I, Scott LM, Wainreb G, Birger Y, Elimelech A, Shochat C, Cazzaniga G, Biondi A, Basso G, Cario G, Schrappe M, Stanulla M, Strehl S, Haas OA, Mann G, Binder V, Borkhardt A, Kempski H, Trka J, Bielorei B, Avigad S, Stark B, Smith O, Dastugue N, Bourquin JP, Tal NB, Green AR, Izraeli S: Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down’s syndrome. Lancet 2008
9. 372 (9648): 1484-1492 9. Kearney L, Gonzalez De Castro D, Yeung J, Procter J, Horsley SW, Eguchi-Ishimae M, Bateman CM, Anderson K, Chaplin T, Young BD, Harrison CJ, Kempski H, So CW, Ford AM, Greaves M: Specific JAK2 mutation (JAK2R683) and multiple gene deletions in Down syndrome acute lymphoblastic leukemia. Blood 2009
10. 113 (3): 646-648 10. Harvey RC, Mullighan CG, Chen IM, Wharton W, Mikhail FM, Carroll AJ, Kang H, Liu W, Dobbin KK, Smith MA, Carroll WL, Devidas M, Bowman WP, Camitta BM, Reaman GH, Hunger SP, Downing JR, Willman CL: Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino e